Tyra Biosciences, Inc. financial data

Symbol
TYRA on Nasdaq
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1893% % -41%
Debt-to-equity 7.2% % 52%
Return On Equity -41% % -75%
Return On Assets -38% % -71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53,867,115 shares 1.5%
Common Stock, Shares, Outstanding 53,706,357 shares 5.8%
Entity Public Float $297,300,000 USD -12%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 59,602,328 shares 4.2%
Weighted Average Number of Shares Outstanding, Diluted 59,602,328 shares 4.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $102,928,000 USD 29%
General and Administrative Expense $29,834,000 USD 24%
Operating Income (Loss) $132,762,000 USD -27%
Nonoperating Income (Expense) $12,815,000 USD -28%
Net Income (Loss) Attributable to Parent $119,947,000 USD -39%
Earnings Per Share, Basic -2.01 USD/shares -33%
Earnings Per Share, Diluted -2.01 USD/shares -33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $77,387,000 USD -16%
Assets, Current $265,450,000 USD -24%
Property, Plant and Equipment, Net $1,314,000 USD -20%
Other Assets, Noncurrent $9,272,000 USD 26%
Assets $282,609,000 USD -22%
Accounts Payable, Current $1,178,000 USD 100%
Liabilities, Current $18,094,000 USD 24%
Operating Lease, Liability, Noncurrent $5,338,000 USD -8.1%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $23,432,000 USD 15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $393,000 USD -49%
Retained Earnings (Accumulated Deficit) $371,258,000 USD -48%
Stockholders' Equity Attributable to Parent $259,177,000 USD -24%
Liabilities and Equity $282,609,000 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,458,000 USD -16%
Net Cash Provided by (Used in) Financing Activities $2,187,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $32,026,000 USD 77%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 53,706,357 shares 5.8%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,755,000 USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78,387,000 USD -16%
Deferred Tax Assets, Valuation Allowance $88,026,000 USD 39%
Deferred Tax Assets, Gross $89,468,000 USD 38%
Operating Lease, Liability $5,810,000 USD -6.6%
Depreciation $500,000 USD 25%
Payments to Acquire Property, Plant, and Equipment $14,000 USD -90%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $120,324,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid $7,813,000 USD -10%
Property, Plant and Equipment, Gross $2,915,000 USD 16%
Operating Lease, Liability, Current $472,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $927,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $900,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.0807 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,003,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $955,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $41,792,000 USD 121%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $8,705,000 USD 57%
Lessee, Operating Lease, Liability, to be Paid, Year Four $983,000 USD 2.9%
Operating Lease, Payments $900,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $143,000 USD 17%
Deferred Tax Assets, Net of Valuation Allowance $1,442,000 USD -6.3%
Share-based Payment Arrangement, Expense $28,006,000 USD 23%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%